Eurasian clinical guidelines for the prevention of cardiovascular diseases in childhood and adolescence (2023)

The EAC Guidelines represent the views  of the  EAC,  and were produced  after careful consideration  of the scientific  and medical knowledge,  and the evidence  available at the time of their publication.

1. Gidding SS, Rana J, Prendergast C, et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score in Young Adults Predicts Coronary Artery and Abdominal Aorta Calcium in Middle Age. The CARDIA Study. Circulation 2016; 133(2):2139-146. https://doi.org/10.1161/circulationaha.115.018042

2. Berenson G., Srinivasan S.R, Bao W et al. for the Bogalusa Heart Study. Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults. .N Engl J Med 1998 Jun 4;338(23):1650-1656. https://doi.org/10.1056/nejm199806043382302

3. Mahoney LT, Burns TL, Stanford W et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcifcation in young adults: the Muscatine Study. J Am Coll Cardiol. 1996; 27(2):277–284. https://doi.org/10.1016/0735-1097(95)00461-0

4. Raitakari OT, Juonala M, Kähönen M et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290(17):2277–2283. https://doi.org/10.1001/jama.290.17.2277

5. Reis JP, Allen N., Gibbs BB et al. Association of the degree of adiposity and duration of obesity with measures of cardiac structure and function: the CARDIA study. Obesity (Silver Spring). 2014;22(11):2434–2440. https://doi.org/10.1002/oby.20865

6. Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36()10:1953–2041. https://doi.org/10.1097/hjh.0000000000001940

7. Mancia G, Kreutz R, Brunstrom M et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023 Jun 21. https://doi.org/10.1097/hjh.0000000000003480

8. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213–S56. https://doi.org/10.1542/peds.2009-2107c

9. Aleksandrov A.A., Bubnova M.G., Kislyak O.A. and et al. Prevention of cardiovascular diseases in childhood and adolescence. Russian recommendations. Russian Journal of Cardiology. 2012; 6(App. 1):1–40 (in Russ.).

10. Adams C., Burke V., Beilin LJ. Cholesterol tracking from childhood to adult mid-life in children from the Busselton study. Acta Paediatr. 2005 Mar;94(3):275-80. https://doi.org/10.1111/j.1651-2227.2005.tb03069.x

11. Rozanov V B, Aleksandrov A A, Perova N V, et al. Primary prevention of cardiovascular diseases: long term results of five year long preventive intervention in 12-year old boys (ten year prospective study). Kardiologiia. 2007;47(8):60-68 (in Russ.).

12. Aleksandrov A.A., Kisliak O.A., Leontyeva I.V. Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents. Systemic Hypertension. 2020;17(2):7-35 (in Russ.). https://doi.org/10.26442/2075082X.2020.2.200126

13. Rosner B, Cook NR, Daniels S, Falkner B. Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988–2008. Hypertension 2013; 62(2):247-54. https://doi.org/10.1161/hypertensionaha.111.00831

14. Lurbe E, Agabiti-Roseic E, Cruickshankd JK et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016; 34(10):1887–1920. https://doi.org/10.1097/hjh.0000000000001039

15. Freedman DS, Khan LK, Serdula MK et al. The relation of menarcheal age to obesity in childhood and adulthood: the Bogalusa heart study. BMC Pediatr. 2003 Apr 30;3:3. https://doi.org/10.1186%2F1471-2431-3-3

16. Weihe P, Weihrauch-Blüher S. Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives. Curr. Obes. Rep. 2019;8(4):472-479. https://doi.org/10.1007/s13679-019-00357-x

17. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: The Princeton Lipid Research Clinics follow-up study. Pediatrics . 2007 Aug;120(2):340-345. https://doi.org/10.1542/peds.2006-1699

18. Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol. 2012;23(4):578–585. https://doi.org/10.1681/asn.2011111115

19. Panico C, Condorelli G. Unmet needs in the pathogenesis and treatment of cardiovascular comorbidities in chronic inflammatory diseases. Clin Rev Allergy Immunol. 2018 Dec;55(3):254-270. https://doi.org/10.1007/s12016-017-8624-5

20. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001 Jul 1;19(13):3163-3172. https://doi.org/10.1200/jco.2001.19.13.3163

21. Mulrooney DA, Yeazel MW, Kawashima T et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606. https://doi.org/10.1136/bmj.b4606

22. Tutarel O. Acquired heart conditions in adults with congenital heart disease: a growing problem. Heart. 2014;100(17):1317–1321. https://doi.org/10.1136/heartjnl-2014-305575

23. Kato H, Sugimura T, Akagi T et al. Long-term consequences of Kawasaki disease: a 10-to 21-year follow-up study of 594 patients. Circulation. 1996; 94(6):1379–1385. https://doi.org/10.1161/01.cir.94.6.1379

24. Giannakoulas G, Dimopoulos K, Engel R et al. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009; 103(10):1445–1450. https://doi.org/10.1016/j.amjcard.2009.01.353

25. Kavey RE, Allada V, Daniels SR et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientifc statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition,Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation. 2006;114(24):2710–2738. https://doi.org/10.1161/circulationaha.106.179568

26. de Ferranti S, Steinberger J, Ameduri R et al. on behalf of the American Heart Association Atherosclerosis, Hypertension and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research. Cardiovascular risk reduction in high-risk pediatric patients. A Scientific Statement from the American Heart Assiociation. Circulation. 2019;139(13):e603–e634. https://doi.org/10.1161/cir.0000000000000618

27. Flynn JT, Kaelber DC, Baker-Smith CM et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140(3):e20171904. https://doi.org/10.1542/peds.2017-1904

28. Lewington S, Clarke R, Qizilbash N et al. for the Prospective Studies Collaboration. Age-specifc relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies [published correction appears in Lancet. 2003;361:1060]. Lancet. 2002 Dec 14;360(9349):1903-13. https://doi.org/10.1016/s0140-6736(02)11911-8

29. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018 Sep 1;39(33):3021-3104. [Erratum in: Eur Heart J. 2019 Feb 1;40(5):475]. https://doi.org/10.1093/eurheartj/ehy339

30. Chazova I.E., Zhernakova Yu.V. Diagnosis and treatment of arterial hypertension [Guidelines]. Systemic Hypertension. 2019;16(1):6-31. (in Russ.). https://doi.org/10.26442/2075082X.2019.1.190179

31. Jebeile H, Kelly AS, O’Malley G et al. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022 May;10(5):351-365. https://doi.org/10.1016/s2213-8587(22)00047-x

32. Childhood Obesity Surveillance Initiative (COSI) Factsheet. Highlights 2015–17. 2018. Available: https://www.who.int/europe/publications/i/item/WHO-EURO-2021-2495-42251-58349

33. Gritsinskaya V.L., Novikova V.P., Khavkin A.I. Epidemiology of obesity in children and adolescents (systematic review and meta-analysis of publications over a 15-year period). Vopr. prakt. pediatr. (Clinical Practice in Pediatrics). 2022;17(2):126–135. (In Russ.). https://doi.org/10.20953/18177646-2022-2-126-135

34. Young Lee, E.; Yoon, K.-H. Epidemic obesity in children and adolescents: Risk factors and prevention. Front. Med. 2018 Dec;12(6):658-666. https://doi.org/10.1007/s11684-018-0640-1

35. Morales Camacho,WJ Díaz M, JM Ortiz PS et al.. Childhood obesity: Aetiology, comorbidities, and treatment. Diabetes Metab. Res. Rev. 2019;35:e3203. http://dx.doi.org/10.1002/dmrr.3203

36. Hampl SE, Hassink SG, Skinner AC et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151(2):e2022060640. https://doi.org/10.1542/peds.2022-060640

37. Clinical guidelines «Obesity in children», 2021 (in Russ.). https://cr.minzdrav.gov.ru/schema/229_2

38. Girsh Y.V., Gerasimchik O.A. The role and place of bioimpedance analysis assessment of body composition of children and adolescents with different body mass. Bulletin of Siberian Medicine. 2018;17(2):121-132. (In Russ.). https://doi.org/10.20538/1682-0363-2018-2-121-132

39. Steinberger J, Daniels SR, Hagberg N et al. on behalf of the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council. Cardiovascular Health Promotion in Children: Challenges and Opportunities for 2020 and Beyond: A Scientific Statement From the American Heart Association. Circulation. 2016;134(12):e236-e255. https://doi.org/10.1161/CIR.0000000000000441

40. McCrindle BW, Urbina EM, Dennison BA et al. «Scientific Statement From the American Heart» Association Atherosclerosis, Hypertension and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing. Circulation. 2007; 115:1948–1967. https://doi.org/10.1161/CIRCULATIONAHA.107.181946

41. de Ferranti SD, Rodday AM, Mendelson MM et al. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation. 2016;133:1067–1072. https://doi.org/10.1161/CIRCULATIONAHA.115.018791

42. Nordestgaard BG, Chapman MJ, Humphries SE et al.; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease:consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013; 34(45): 3478-90а. https://doi.org/10.1093/eurheartj/eht273

43. Perak AM, Ning H, de Ferranti SD et al. Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype. Circulation. 2016; 134:9–19. https://doi.org/10.1161/circulationaha.116.022335

44. Ezhov M.V., Bazhan S.S., Ershova A.I., et al. Clinical guidelines for familial hypercholesterolemia. Ateroscleroz. 2019;15(1):58-98. (In Russ.).

45. Kusters DM, de Beaufort C, Widhalm K et al. Paediatric screening for hypercholesterolaemia in Europe. Arch Dis Child. 2012;97:272–276. https://doi.org/10.1136/archdischild-2011-300081

46. Patni N, Ahmad Z, Wilson DP. Genetics and Dyslipidemia. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; February 11, 2020. PMID: 27809445

47. Kurbanismailova P.M., Popova A.B., Dranenko N.Yu., Sergienko I.V. Aspects of detecting patients with family hypercholesterolemia. Clinical practice. 2017;3:61-69 (in Russ).

48. Tsanava I.A., Sharonova L.A., Verbovoy A.F. Metabolic syndrome and cardiovascular diseases. RMJ 2017; 11:785-789 (in Russ.).

49. Al-Beltagi M, Bediwy AS, Saeed NK. Insulin-resistance in paediatric age: Its magnitude and implications. World J Diabetes. 2022; 13(4):282–307. https://doi.org/10.4239/wjd.v13.i4.282

50. Castorani V, Polidor N, Giannini C et al. Insulin resistance and type 2 diabetes in children. Ann Pediatr Endocrinol Metab. 2020; 25(4):217–226. https://doi.org/10.6065/apem.2040090.045

51. Harmonizing the metabolic syndrome: a joint interim statement of the IDF, NHLBI, AHA, WHF, IAS, IASO. Circulation, 2009, Oct 20, 120(16):1640-1645. http://dx.doi.org/10.14341/2071-8713-5281

52. Zimmet P, Alberti KG, Kaufman F et al. IDF Consensus Group. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes. 2007; 8(5):299–306. https://doi.org/10.1111/j.1399-5448.2007.00271.x

53. Sakharova G.M., Antonov N.S., Salagay O.O., Donitova V.V. Global survey on tobacco consumption by young subjects 13 to 15 years of age in Russian Federation (2004 – 2015). Pulmonologiya. 2017;27(2):179-186. (In Russ.). https://doi.org/10.18093/0869/0189/2017/27(2)179-186

54. Oberg M, Jaakkola MS, Woodward A et al. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377(9760):139-146. https://doi.org/10.1016/S0140-6736(10)61388-8

55. Rosen LJ, Myers V, Hovell M et al. Meta-analysis of parental protection of children from tobacco smoke exposure. Pediatrics. 2014;133:698–714. https://doi.org/10.1542/peds.2013-0958

56. Yang H, Ma C, Zhao M et al. Prevalence and trend of smokeless tobacco use and its associated factors among adolescents aged 12–16 years in 138 countries/territories, 1999–2019. BMC Med . 2022 Nov 25;20(1):460. https://doi.org/10.1186/s12916-022-02662-0

57. National Cancer Institute and Centers for Disease Control and Prevention. Smokeless Tobacco and Public Health: A Global Perspective. Bethesda, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, National Cancer Institute. NIH Publication No. 14-7983; 2014.

58. WHO guidelines on physical activity and sedentary behavior. Geneva: World Health Organization; 2021; 104 p.

59. US Department of Health and Human Services. Physical Activity Guidelines for Americans. US Department of Health and Human Services. 2008 Url: www.health.gov/paguidelines

60. Janssen I. Physical activity guidelines for children and youth. Can J Public Health. 2007; 98 (Suppl. 2): S109–21. PMID: 18213942

61. Ainsworth BE, Haskell WL, Whitt MC et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32(9 Suppl):S498-504. https://doi.org/10.1097/00005768-200009001-00009

62. 2021 Dietary guidance to improve cardiovascular health: a scientific statement from American Heart Association. Circulation . 2021 Dec 7;144(23):e472-e487. https://doi.org/10.1161/cir.0000000000001031

63. Styne DM, Arslanian SA, Connor EL et al. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017 Mar 1;102(3):709-757. https://doi.org/10.1210/jc.2016-2573

64. Peterson AL, McNeal CJ, Wilson DP. Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia. Curr Atheroscler Rep. 2021 Aug 27;23(10):64. https://doi.org/10.1007/s11883-021-00959-8

65. Yeung J, Chisholm K, Spinks C et al. Familial hypercholesterolaemia: Experience of a tertiary paediatric lipid clinic. J Paediatr Child Health. 2021 Aug;57(8):1201-1207. https://doi.org/10.1111/jpc.12036